The hypothesis that renal a2 adrenoceptors influence nephron filtration rate (SNGFR) via interaction with angiotensin II (All) was tested by renal micropuncture. The physical determinants of SNGFR were assessed in adult male Munich Wistar rats 5-7 d after ipsilateral surgical renal denervation (DNX). DNX was performed to isolate inhibitory central and presynaptic a2 adrenoceptors from end-organ receptors within the kidney. Two experimental protocols were employed: one to test whether prior All receptor blockade with saralasin would alter the glomerular hemodynamic response to a2 adrenoceptor stimulation with the selective agonist B-HT 933 under euvolemic conditions, and the other to test whether B-HT 933 would alter the response to exogenous All under conditions of plasma volume expansion. In euvolemic rats, B-HT 933 caused SNGFR to decline as the result of a decrease in glomerular ultrafiltration coefficient (LpA), an effect that was blocked by saralasin. After plasma volume expansion, B-HT 933 showed no primary effect on LpA but heightened the response of arterial blood pressure, glomerular transcapillary pressure gradient, and LpA to All. The parallel results of these converse experiments suggest a complementary interaction between renal a2-adrenergic and All systems in the control of LpA. (J. Clin. Invest. 1992. 
Introduction
The renal glomerulus is replete with a2 adrenoceptors ( 1) , but the physiological role of these receptors is not easily demonstrated. Conflicting data have resulted from various attempts to study the potential hemodynamic effects ofa2 receptor stimulation at either the whole kidney or single nephron level. We previously suspected that inconsistent renal hemodynamic responses to a2 receptor stimulation might result from opposing hemodynamic effects ofstimulating central or presynaptic versus post-or extrajunctional a2 receptors. This hypothesis was confirmed by comparing the glomerular hemodynamic effects March 1992. of the a2 agonist, B-HT 933, in rats previously subjected to renal denervation versus rats with the renal nerves intact (2) . When B-HT 933 was administered to animals with normally innervated kidneys, single nephron GFR (SNGFR) increased due to an increase in nephron plasma flow, but when it was administered to animals after renal denervation, SNGFR de- creased because of a decrement in ultrafiltration coefficient. Renal denervation thus appeared to unmask effects of a2 agonist administration on the kidney that are not dependent upon renal nerves and that cause ultrafiltration coefficient and SNGFR to decrease.
The present studies were undertaken to ascertain whether these effects of a2 receptor stimulation in the denervated kidney might involve a functional interaction with angiotensin II (All), since All is well known to exert local control over the determinants of SNGFR through effects on vascular resistances and glomerular ultrafiltration coefficient (LpA) (3 Group 2B (n = 7) was the control for group 2A, with Ringers' saline in place of SAR.
Denervation procedure. Renal denervation was carried out 5-7 d before micropuncture under sterile operating conditions according to protocols as previously described (2) . We have previously demonstrated uniform success in achieving renal sympathetic denervation by these means as documented by a > 90% reduction in renal tissue norepinephrine (4, 5) .
Micropuncture experiments. Micropuncture was performed under Inactin (Andrew Lockwood Assoc., Ann Arbor, MI) anesthesia according to protocols previously described in publications from this laboratory (6) . Animals studied under euvolemic conditions received donor rat plasma as surgical replacement ( 11 ml/kg body wt over 60 min) followed by continuous infusion ( 1.5 ml/kg per h). Animals undergoing plasma volume expansion received donor rat plasma (25 ml/kg body wt over 60 min) followed by continuous infusion of Ringers' saline (4.8 ml/h). All animals received an additional infusion of Ringers' saline containing 80 uCi/ml [3H]inulin (1.5 ml/h) as a marker of glomerular filtration.
Arterial blood pressure was monitored from a femoral artery catheter. Hydrostatic pressures were measured directly in glomerular capillaries (PGc), Bowman's space (PBS), and efferent arterioles (PE) with a servo-nulling pressure device using micropipettes filled with hypertonic saline. Systemic blood was sampled from the femoral artery. Efferent arteriolar blood was obtained by direct micropuncture. A microadaptation of the Lowry technique (7) was used to determine the protein concentrations of systemic (CA) and efferent arteriolar (CE) plasma. Plasma oncotic pressure (ir) was calculated from protein concentration by the Landis-Pappenheimer equation (8) . Nephron filtration fraction was computed from CA and CE. Inulin clearance and volumetric measurement of fluid collected from late proximal tubules (five per experimental period) were used to calculate SNGFR and late proximal flow rate (VLP). Absolute and fractional rates of proximal reabsorption were calculated from SNGFR and VLP. (9) . For parameters measured more than once during an experimental period (SNGFR, VLP, FRp, ARP, PGC, PE, and AP), the mean for that period was used. For these parameters, groups were also compared by standard two-way ANOVA using individual measurements. The results of analyses by these two methods were similar.
As has been previously discussed (4), LpA, as estimated by the above method, is likely not to be a normally distributed. Despite the limitation imposed by small sample sizes, an indication of whether or not a variable is normally distributed may be ascertained from the linearity of a Normal Probability Plot ( 10) . Such plots constructed for LpA indicated that LpA was as likely to be distributed log-normally as normally. For this reason values of Log(LpA) as well as LpA were subjected to repeated measures ANOVA.
Results
Experimental results are depicted in Tables I and II Systemic and whole kidney effects Effects ofB-HT 933 in euvolemia with and without saralasin.
Among euvolemic animals, arterial pressure (BP) did not differ significantly between those receiving saralasin and controls. B-HT 933 reduced BP by -10 mmHg in both groups (P = 0.001). Saralasin did not alter the effect of B-HT 933 on blood pressure. B-HT 933 exerted a similar diuretic effect in left and right kidneys, independent of saralasin. In the denervated left kidney, GFR declined with B-HT 933 administration in control, but not saralasin-treated, animals. Similar effects on GFR were observed in the innervated right kidney, although the effect ofB-HT 933 in control animals did not achieve statistical significance (P = 0.06 by paired t test).
Effects ofAII afterplasma volume expansion with and without B-HT 933. Before receiving All, volume-expanded animals treated with B-HT 933 tended toward lower blood pressures commensurate with the expected central sympatholytic effect of the a2 agonist. All caused BP to increase by an amount similar to that previously reported with this dose (5) . After All infusion, the mean BP was similar between B-HT 933-treated and control groups but the incremental increase in BP after All administration was greater in animals pretreated with B-HT 933.
B-HT 933 exerted a diuretic effect that was most pronounced in the innervated right kidney, whereas a pressure diuresis after All administration was noted only in the left kidney. Fractional hematocrit increased slightly with All administration. This effect was not dependent on B-HT 933, suggesting that B-HT 933 administration was not a determinant ofplasma volume. The rate of saline infusion exceeded the rate of urine flow by -30 and 70 Al/min in B-HT 933 and control animals, respectively.
Glomerular hemodynamics
Effects ofB-HT 933 in euvolemia with and without saralasin. In euvolemic animals, PGC was not affected by saralasin but declined somewhat with the administration of B-HT 933, perhaps reflecting incomplete autoregulation. The first period mean AP was 2.3 mmHg higher in the saralasin group, a finding of stochastic (P = 0.05), but not quantitative significance. EFPa and SNPF, however, were unaffected by either treatment. Filtration pressure disequilibrium prevailed throughout both experimental periods in 5/7 control animals and in 6/6 animals receiving saralasin, enabling calculation of unique values Proximal tubular reabsorption Effects ofB-HT 933 in euvolemia with and without saralasin. The effects ofB-HT 933 and saralasin on the delivery offluid to the late proximal tubule tended to parallel the effects on SNGFR. Fractional reabsorption was enhanced by B-HT 933 in both groups and tended to be less in animals receiving SAR. Net fluid reabsorption from the proximal tubule was diminished in the presence of saralasin but unaffected by B-HT 933.
Effects ofAIl afterplasma volume expansion with and without B-HT 933. In volume-expanded animals, no independent effect of B-HT 933 was demonstrated on absolute or fractional reabsorption of fluid from the proximal tubule. Absolute reabsorption fell along with the filtered load whereas fractional reabsorption increased with All administration in both groups. The increase in fractional reabsorption after All was numerically greater in the B-HT 933-treated group, although this effect of B-HT 933 was not statistically significant.
Discussion
Although the physiological role of renal a2 adrenoceptors remains to be fully established, they have been reported to constrict (11) (12) (13) or relax (2) the renal vasculature, suppress renin secretion (14, 15) , and stimulate reabsorption ofsodium from the proximal nephron by stimulating Na/H exchange (16) (17) (18) and from the loop ofHenle by suppressing furosemide- (19) or prostaglandin-(20) mediated increases in cAMP. a2 Receptors also inhibit reabsorption of salt and water from the distal nephron by antagonizing the effects of vasopressin (21) (22) (23) (24) (25) and potentiating the effect ofatrial natriuretic peptide (26) . In many of these cases, a2 adrenoceptors function by modulating the activity of other effector systems (16) (17) (18) (27) (28) (29) (30) (31) (32) (33) . In situations where a2 receptors modulate the influence of multiple effectors, the physiological outcome of a2 receptor stimulation or blockade will depend upon the previous activities of potentially competing systems that are individually conditioned by interactions with a2 adrenoceptors. The present studies were formulated to ascertain whether previously reported effects of a2 adrenoceptor stimulation on glomerular dynamics involve an interaction with All. The basis for this hypothesis derives in part from similarities between the recently reported glomerular hemodynamic response to B-HT 933 (2) and the well-known response to All (3), as well as from past reports that angiotensin-converting enzyme inhibitors will block a2-mediated vasoconstriction (34) (35) (36) . Studies were performed after renal denervation to isolate the effects of stimulating renal a2 receptors from the sympathoinhibitory actions of systemic a2 agonist administration. Although changes may occur in the density and distribution of renal a2 adrenoceptors when nerve signaling is interrupted by a, receptor blockade (37), subacute surgical denervation does not alter the density of a2 adrenoceptors within glomeruli (2) so that glomerular hemodynamic response to B-HT 933 observed in the denervated kidney are not mere reflections of denervation hypersensitivity.
To block the effects of the renin-AII system, saralasin was chosen in preference to a converting enzyme inhibitor in order to avoid the potentially confounding influence of the latter on kinin degradation (38) . The dose of saralasin used was sufficient to decrease by > 90% the pressor response to a bolus injection of AII (70 ng/kg intravenously).
Given that a2 and All receptors are both widely distributed and that each may exert influence over vascular tone and epithelial transport at numerous sites it is not surprising that the various experimental treatments altered systemic hemodynamics, nephron plasma flow, glomerular ultrafiltration coefficient, proximal tubular reabsorption, and urine flow. The effects of administering All (5) and B-HT 933 (2) to control animals after subacute renal denervation are similar to those previously reported. The enhanced diuretic effect of a2 receptor stimulation associated with volume expansion has also been previously reported (39) . Statistically significant interactions between the a2-adrenergic and All systems were observed in euvolemic animals with regard to nephron and whole kidney GFR and glomerular ultrafiltration coefficient. In volume-expanded animals, significant interactions were noted with regard to effects on systemic blood pressure, nephron plasma flow, AP, whole kidney GFR, and glomerular ultrafiltration coefficient. Among the physiological determinants of SNGFR, therefore, the a2 and AII systems manifest interdependence in their control of nephron plasma flow, intraglomerular hydrostatic pressures, and glomerular ultrafiltration coefficient. Each of these interactions is complementary except for that involving nephron plasma flow after volume expansion.
In a complex physiological model, in which the a2 and All systems interact to control multiple parameters, it is likely that they do so through multiple mechanisms. Several investigators have undertaken to delineate the roles of the adrenergic receptor subtypes in the control of renal blood flow. A number of functional and pharmacological studies in anesthetized animals have suggested that renal vasoconstriction, whether elicited by renal sympathetic nerve activity or adrenergic agonist infusion, is mediated by a, receptors (40) (41) (42) . In fact, administration of B-HT 933 to euvolemic rats with intact renal nerves resulted in an actual increase in nephron plasma flow despite a decline in blood pressure (2) , probably because ofsuppression of efferent renal sympathetic nerve activity by central (30) or peripheral presynaptic a2 receptors (29, 30, 43, 44) . a2-Mediated renal vasoconstriction has been demonstrated, however, in awake rats ( 13, 45 ) , sheep ( I1), and humans ( 12) , suggesting the possibility of a saturable vasomotor response that is obscured by the increase in circulating catecholamines accompanying general anesthesia (46) . The present study confirms the previous finding, that a2 agonist administration does not alter nephron plasma flow in the euvolemic anesthetized rat after renal denervation (2). After 2.5% plasma volume expansion, however, nephron plasma flow is somewhat less among animals receiving B-HT 933 than among controls. Since PGC and PE were both elevated despite a lower arterial blood pressure in the group receiving the a2 agonist, the difference in SNPF appears to have been mediated by a combination of lower arterial blood pressure and a greater vascular resistance in segments downstream from the efferent arteriole. The differa2-Adrenergic Angiotensin II Interactions and Glomerular Hemodynamics 609 ence in SNPF between the two groups of volume-expanded animals does not depend on differences in the resistance of vascular segments between the aorta and peritubular capillary. The fact that this finding was limited to volume-expanded animals probably reflects a decreased residual capacitance of the venous system and, therefore, greater sensitivity to a2-mediated venoconstriction under this condition. In contrast, when B-HT 933 was given to euvolemic animals, PGc and PE actually declined along with BP while SNPF was preserved, findings which exclude selective postrenal vasoconstriction in euvolemia.
An inhibitory interaction between renal a2 adrenoceptors and the renin-angiotensin system has been previously documented ( 15 teractions that occur at the cellular versus those which occur at the systemic level. Nonetheless, such data do provide information regarding the physiological relevance of these interactions and the plausibility of hypotheses to explain them. For instance, the likelihood that an interaction is mediated locally rather than via events in distant organs increases if it holds under different conditions or with contradictory perturbation of the components under study. Among the parameters measured, only LpA manifested a statistically significant interdependence between the All and a2 systems during both stimulation and inhibition of All activity. Although not excluding the possibility of other local interactions between the two systems, these findings enhance the plausibility of the notion that the two systems could interact within the glomerulus to govein LpA.
A facilitory interdependence has been previously observed between the All and a2-adrenergic systems in the arterial vasculature (35, 36, 47) where inhibition of All will blunt a2-mediated vasoconstriction by mechanisms that remain to be elucidated. Since certain shared properties ofthe contractile mesangium and vascular smooth muscle could account for the functional control that the former, as a site ofaction for various hormones and autacoids, may exert over the glomerular ultrafiltration coefficient (48) , it is conceivable that the mechanism of interaction between All and the a2-adrenergic subsystem in the renal glomerulus and arterial vasculature are the same.
To summarize, a2 adrenoceptor stimulation in euvolemic rats after ipsilateral renal denervation causes SNGFR to decrease as the result of a decrease in glomerular ultrafiltration coefficient. The effects of a2 agonist administration on glomerular ultrafiltration coefficient and SNGFR under these conditions are eliminated by previous treatment with the All receptor antagonist saralasin or by plasma volume expansion. a2 Adrenoceptor stimulation in volume-expanded rats after ipsilateral renal denervation amplifies the well-known effects of All on blood pressure, glomerular capillary pressure gradient, and glomerular ultrafiltration coefficient. A positive interaction between the a2-adrenergic and All systems in the control of LpA seems particularly likely, having been demonstrated by two converse means, first as a tendency for B-HT 933 to heighten the response to All and then as a proclivity for saralasin to inhibit the response to B-HT 933. Furthermore, the effect ofthe a2 agonist on LpA was eliminated by plasma volume expansion. Since suppression of endogenous renin is among the hormonal effects of plasma volume expansion, the role of volume status in conditioning the effect of B-HT 933 on LpA provides additional circumstantial evidence that a2 adrenoceptors function within the glomerulus to amplify the local physiological response to All. Whether interactions between the a2-adrenergic and angiotensin systems are mediated by events within single cells as well as at the end-organ level is a subject for further investigation.
